EGFR and non-small cell lung carcinoma: Our findings indicated that panduratin A, isolated from B. rotunda, exhibits significant anti-lung cancer activity and presents a promising therapeutic option for NSCLC patients with both the wild-type and mutant EGFR, while also demonstrating low toxicity to MRC5 normal cells.